107 related articles for article (PubMed ID: 1959340)
1. Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay.
Nakatsuka K; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H; Ogata E
Contrib Nephrol; 1991; 90():147-54. PubMed ID: 1959340
[TBL] [Abstract][Full Text] [Related]
2. Technical and clinical validation of a new immunoradiometric assay for human osteocalcin.
Dumon JC; Wantier H; Mathieu F; Mantia M; Body JJ
Eur J Endocrinol; 1996 Aug; 135(2):231-7. PubMed ID: 8810739
[TBL] [Abstract][Full Text] [Related]
3. Two-site assays of bone gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule.
Deftos LJ; Wolfert RL; Hill CS; Burton DW
Clin Chem; 1992 Nov; 38(11):2318-21. PubMed ID: 1385019
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
[TBL] [Abstract][Full Text] [Related]
5. A radioimmunoassay for bone Gla protein (BGP) in human plasma.
Johansen JS; Mølholm Hansen JE; Christiansen C
Acta Endocrinol (Copenh); 1987 Mar; 114(3):410-6. PubMed ID: 3494371
[TBL] [Abstract][Full Text] [Related]
6. Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.
Miki T; Nakatsuka K; Nishizawa Y; Emoto M; Morita A; Tabata T; Matsushita Y; Inoue T; Morii H
Endocrinol Jpn; 1991 Oct; 38(5):479-83. PubMed ID: 1843267
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
Sugimoto K; Dohi Y; Dohi K; Yonemasu K; Fujimoto J; Kanauchi M; Yamanaka F; Moriyama T; Ishikawa H
Miner Electrolyte Metab; 1987; 13(3):152-7. PubMed ID: 3498115
[TBL] [Abstract][Full Text] [Related]
8. Measurement of serum bone gla-protein (BGP) in humans with an ovine BGP-based radioimmunoassay.
Pastoureau P; Delmas PD
Clin Chem; 1990 Sep; 36(9):1620-4. PubMed ID: 2208702
[TBL] [Abstract][Full Text] [Related]
9. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
Garnero P; Grimaux M; Seguin P; Delmas PD
J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
Malluche HH; Faugere MC; Fanti P; Price PA
Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
[TBL] [Abstract][Full Text] [Related]
11. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
Epstein S; Traberg H; Raja R; Poser J
J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive osteocalcin forms in conditioned media from human osteoblast culture and in sera from healthy adult control subjects and patients with bone pathologies.
Diaz Diego EM; Nacher M; Rapado A; Serrano S; Bosch J; Aubia J; de la Piedra C
Eur J Clin Invest; 1998 Jan; 28(1):48-58. PubMed ID: 9502187
[TBL] [Abstract][Full Text] [Related]
13. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up.
Coen G; Mazzaferro S; Bonucci E; Taggi F; Ballanti P; Bianchi AR; Donato G; Massimetti C; Smacchi A; Cinotti GA
Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905
[TBL] [Abstract][Full Text] [Related]
14. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin].
Kong Y; Meng X; Zhou X; Liu H; Liu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma bone GLA protein during treatment of bone disease.
Deftos LJ; Parthemore JG; Price PA
Calcif Tissue Int; 1982 Mar; 34(2):121-4. PubMed ID: 6805917
[TBL] [Abstract][Full Text] [Related]
16. Cigarette Smoking is Associated with Decreased Bone Gla-protein (BGP) Levels in Hemodialysis Patients.
Fusaro M; Gallieni M; Aghi A; Iervasi G; Rizzo MA; Stucchi A; Noale M; Tripepi G; Nickolas T; Veronese N; Fabris F; Giannini S; Calo L; Piccoli A; Mereu MC; Cosmai L; Ferraro A; Magonara F; Spinello M; Sella S; Plebani M
Curr Vasc Pharmacol; 2018; 16(6):603-609. PubMed ID: 28933309
[TBL] [Abstract][Full Text] [Related]
17. Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications.
Bataille R; Delmas PD; Chappard D; Sany J
Cancer; 1990 Jul; 66(1):167-72. PubMed ID: 2354403
[TBL] [Abstract][Full Text] [Related]
18. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.
Fanti P; Smith AJ; Price PA; Reitz RE; Malluche HH
J Clin Endocrinol Metab; 1986 May; 62(5):869-73. PubMed ID: 3485651
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute increases in bone matrix degradation on circulating levels of bone-Gla protein.
Riggs BL; Tsai KS; Mann KG
J Bone Miner Res; 1986 Dec; 1(6):539-42. PubMed ID: 3509744
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum bone Gla protein and urinary gamma-Gla as biochemical markers in primary hyperparathyroidism.
Yoneda M; Takatsuki K; Oiso Y; Takano T; Kurokawa M; Ota A; Tomita A; Ohno T; Okano K; Kanazawa T
Endocrinol Jpn; 1986 Feb; 33(1):89-94. PubMed ID: 3487445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
